Doppelganger Biosystem GmbH

At Doppelganger Biosystem GmbH, we are at the forefront of patient digital twin technology. Our QSM™ platform enables a deep understanding of disease mechanisms and quantitative pharmacology, while our breakthrough QSM™ twins empower QSP modelers to de-risk drug development programs. By delivering precision simulations for personalized therapies, we aim to transform healthcare and improve patient outcomes. Join us in our mission to revolutionize the future of medicine.